Logo
x

Search category

Subscribe Now

Advanced Renal

Merck & Co's Keytruda (pembrolizumab) Receives Health Canada's Approval as 1L Treatment for Advanced Renal Cell Carcinoma

Merck & Co's Keytruda (pembrolizumab) Receives Health Canada's Approval as 1L Treatment for Advanced Renal Cell Carcinoma

  • January 23, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.